Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 15 of 29
-
COVID-19: Local manufacturing essential if we are to “treat all”
ITPC led a virtual roundtable last week (26 May 2020) attended by civil society treatment experts, researchers, and national pharmaceutical...
-
Jeed: HIV treatment was like winning the lottery
Interviewed by Gemma Taylor. “I was diagnosed with HIV at 21, in 1995. Treatment wasn’t available in Thailand at the...
-
“Children are suffering side-effects from sub-standard HIV treatment”
The longer that HIV antiretroviral drugs (ARVs) have been around, the more that is being discovered about long-term side-effects. In...
-
Moroccan civil society calls for compulsory licence on Gilead’s possible COVID-19 drug
On 12 May 2020, Gilead Sciences announced voluntary licenses to five generic manufacturers in India and Pakistan allowing them to...
-
Brazil and Thailand: Activists oppose more TB patents during COVID-19 pandemic
Bedaquiline (BDQ) is a core component of an ‘all-oral’ solution to multi-drug resistant TB (MDR-TB), and is recommended by the...
-
Civil society asks WHO and Unitaid to ensure equitable access to COVID-19 technologies – and that commitment is binding
In an open letter, sent to Unitaid, the World Health Organization (WHO) and its Member States today, 86 civil society...
-
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
AbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
-
COVID-19 pandemic: ‘An opportunity of a lifetime’?
The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be found...
-
Global headlines: Potential COVID-19 drugs are over-priced
From the front page of Le Monde, to the Financial Times, Bloomberg, Al Jazeera and others, research demonstrating that potential...
-
Postponed: Global Summit on Intellectual Property and Access to Medicines
The 2020 summit will now take place at a later date, at a time when we are assured that international...
-
Open letter: Prepare NOW for equitable access to COVID-19 treatments in Eastern Europe and Central Asia
Organizations working on health and rights in the Eastern Europe and Central Asia (EECA) region, have called on governments to...
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Drugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...